The global mice model market size was USD 1.22 Billion in 2019 and is expected to reach USD 2.00 Billion by 2027, at a CAGR of 6.8% during the forecast period. The global mice model market is likely to expand significantly in the near future, owing to the increasing demand for humanized mice prototypes. The global mice model market is anticipated to be also driven by the increasing use of mice models in the study of virology and contagious diseases.
The latest industry intelligence report on the Mice Model Market performs a cautious examination of the current business environment and competitive landscape of the Mice Model Market for the forecast period, 2020 - 2027. For stakeholders, field marketing executives and product owners planning to maintain a competitive edge the market assessment report brings to light essential impression about the growth rate, share and size of the industry during the estimated period. Deep dive into an array of elements including but not limited to the value proposition, product positioning, and targeting and industry segmentation have been described through resources such as charts, tables, and info graphics.
Read more@ https://www.emergenresearch.com/industry-report/mice-model-market
Competitive Landscape
Envigo Ltd
TransViragen Inc.
Charles River Laboratories International Inc.
GenOway S.A.
The Jackson Laboratory
Ozgene Pty Ltd
GVK Biosciences Private Limited
Taconic Biosciences, Inc.
Pharmaron, Inc.
Horizon Discovery Group plc
You Can Download Free Sample PDF Copy of Mice Model Market at https://www.emergenresearch.com/request-sample/457
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
Facebook | LinkedIn | Twitter | Blogs